Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.

Chang JE, Khuntia D, Robins HI, Mehta MP.

Clin Adv Hematol Oncol. 2007 Nov;5(11):894-902, 907-15. Review.

PMID:
18185489
2.

Radiation therapy of glioblastoma.

Barani IJ, Larson DA.

Cancer Treat Res. 2015;163:49-73. doi: 10.1007/978-3-319-12048-5_4. Review.

PMID:
25468225
3.

Role of radiation therapy and radiosurgery in glioblastoma multiforme.

Fiveash JB, Spencer SA.

Cancer J. 2003 May-Jun;9(3):222-9. Review.

PMID:
12952307
4.

Current strategies in whole-brain radiation therapy for brain metastases.

Mehta MP, Khuntia D.

Neurosurgery. 2005 Nov;57(5 Suppl):S33-44; discusssion S1-4. Review.

PMID:
16237287
5.

Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.

Spiegel BM, Esrailian E, Laine L, Chamberlain MC.

CNS Drugs. 2007;21(9):775-87. Review.

PMID:
17696576
6.

Designer therapies for glioblastoma multiforme.

Sathornsumetee S, Rich JN.

Ann N Y Acad Sci. 2008 Oct;1142:108-32. doi: 10.1196/annals.1444.009. Review.

PMID:
18990124
7.

[Radiotherapy of adult glial tumors: new developments and perspectives].

Maire JP, Huchet A, Catry-Thomas I.

Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):531-41. doi: 10.1016/j.neurol.2008.03.010. Epub 2008 Jun 6. Review. French.

PMID:
18565351
8.

Motexafin gadolinium: a possible new radiosensitiser.

Rodrigus P.

Expert Opin Investig Drugs. 2003 Jul;12(7):1205-10. Review.

PMID:
12831354
9.

Therapeutic advances for glioblastoma multiforme: current status and future prospects.

Robins HI, Chang S, Butowski N, Mehta M.

Curr Oncol Rep. 2007 Jan;9(1):66-70. Review.

PMID:
17164050
10.

Radiation therapy for malignant astrocytomas in adults.

Mornex F, Nayel H, Taillandier L.

Radiother Oncol. 1993 Jun;27(3):181-92. Review.

PMID:
8210454
11.

Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.

Chang SM, Butowski NA, Sneed PK, Garner IV.

Neurosurg Focus. 2006 Apr 15;20(4):E4. Review.

PMID:
16709035
12.

Therapeutic advances in the treatment of brain metastases.

Chang JE, Robins HI, Mehta MP.

Clin Adv Hematol Oncol. 2007 Jan;5(1):54-64. Review.

PMID:
17339829
13.

Non-cytotoxic radiosensitizers in brain radiotherapy: journey till the first decade of this millennium.

Mohindra P, Sinha RN, Andrews RJ, Khuntia D.

Curr Cancer Drug Targets. 2012 Mar;12(3):260-78. Review.

PMID:
22268387
14.

Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer.

Evens AM.

Curr Opin Oncol. 2004 Nov;16(6):576-80. Review.

PMID:
15627019
15.

Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

Lefranc F, Rynkowski M, DeWitte O, Kiss R.

Adv Tech Stand Neurosurg. 2009;34:3-35. Review.

PMID:
19368079
16.

Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.

Weinmann M, Welz S, Bamberg M.

Curr Med Chem Anticancer Agents. 2003 Sep;3(5):364-74. Review.

PMID:
12871083
17.

Glioblastoma in the elderly: current and future trends.

Brandes AA, Compostella A, Blatt V, Tosoni A.

Crit Rev Oncol Hematol. 2006 Dec;60(3):256-66. Epub 2006 Oct 5. Review.

PMID:
17027278
18.

Stereotactic Radiosurgery for Glioblastoma.

Redmond KJ, Mehta M.

Cureus. 2015 Dec 17;7(12):e413. doi: 10.7759/cureus.413. Review.

19.

Present and potential future issues in glioblastoma treatment.

Lefranc F, Sadeghi N, Camby I, Metens T, Dewitte O, Kiss R.

Expert Rev Anticancer Ther. 2006 May;6(5):719-32. Review.

PMID:
16759163
20.

Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma.

Nieder C, Astner ST, Mehta MP, Grosu AL, Molls M.

Am J Clin Oncol. 2008 Jun;31(3):300-5. doi: 10.1097/COC.0b013e31815e3fdc. Review.

PMID:
18525311

Supplemental Content

Support Center